en · de · es
analytical-notes.peptides5388.com › News › Background And Research Status — Worked Examples

Background And Research Status — Worked Examples

By Editorial Desk · published 2025-08-24 · last reviewed 2025-09-14 · News

If you have been reading about anti-doping and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-09-14. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Research Status

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

SR9009 Background and Receptor Mechanism

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Sr9009 at a glance

PropertyValueNotes
Common nameSR9009Also referred to as Stenabolic in non-scientific contexts.
Chemical classSynthetic small moleculeNot a steroid or peptide hormone.
Receptor targetREV-ERBα and REV-ERBβNuclear receptor agonist in preclinical studies.
Development statusInvestigationalNo approved human therapeutic indication.
Regulatory attentionProhibited in sportListed by anti-doping authorities.

Handling, Analysis, and Regulation

Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.

Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.

Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.

Related pages on this site

Handling Storage and Quality Control

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Identity, Handling, and Regulation

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Analytical Detection and Regulatory Status

Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.

Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.

Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.

Supporting material

Partition coefficients can also be defined when one of the phases is solid, for instance, when one phase is a molten metal and the second is a solid metal, or when both phases are solids. The partitioning of a substance into a solid results in a solid solution. Partition coefficients can be measured experimentally in various ways (by shake-flask, HPLC, etc.) or estimated by calculation based on a variety of methods (fragment-based, atom-based, etc.). If a substance is present as several chemical species in the partition system due to association or dissociation, each species is assigned its own Kow value. A related value, D, does not distinguish between different species, only indicating the concentration ratio of the substance between the two phases.

=== Oxygen and small molecule dependent degrons === The presence of oxygen or other small molecules can influence degron recognition. The von Hippel-Lindau (VHL) protein (substrate recognition part of a specific E3 ligase), for instance, recognizes the hypoxia-inducible factor alpha (HIF-α) only under normal oxygen conditions, when its proline is hydroxylated. Under hypoxia, on the other hand, HIF-a is not hydroxylated, evades ubiquitination and thus operates in the cell at higher concentrations which can initiate transcriptional response to hypoxia. Another example of small molecule control of protein degradation is phytohormone auxin in plants. Auxin binds to TIR1 (the substrate recognition domain of SCFTIR1ubiquitin ligase) increasing the affinity of TIR1 for its substrates (transcriptional repressors: Aux/IAA), and promoting their degradation.

. This Laplacian term can be interpreted as the difference between the velocity at a point and the mean velocity in a small surrounding volume. This implies that – for a Newtonian fluid – viscosity operates as a diffusion of momentum, in much the same way as the heat conduction. In fact neglecting the convection term, incompressible Navier–Stokes equations lead to a vector diffusion equation (namely Stokes equations), but in general the convection term is present, so incompressible Navier–Stokes equations belong to the class of convection–diffusion equations. In the usual case of an external field being a conservative field:

==== Alcohol douse ==== Whether or not an alcohol bath is used to cool the irons, the area must be soaked with alcohol again just before branding. This second alcohol soak provides some evaporative cooling of the animal's skin but much more importantly creates an interface between flesh and brand head, greatly enhancing heat transfer while also reducing the amount of time a brand must be pressed into the animal's skin. Pre-wetting the animal's skin with alcohol also prevents the iron from sticking to the frozen skin when liquid nitrogen is used, as frozen alcohol is mechanically very weak compared to the varieties of water ice encountered at cryogenic temperatures.

==== Clemency ==== In response to the Trump administration's crackdown on immigrants with criminal records, Newsom gave heightened consideration to people in this situation. A pardon can eliminate the grounds for deportation of immigrants who would otherwise be legal permanent residents. Pardon requests from people facing deportation are given expedited review by the state Board of Parole Hearings, per a 2018 California law. In his first acts of clemency as governor, Newsom pardoned seven formerly incarcerated people in May 2019, including two Cambodian refugees facing deportation. He pardoned three men who were attempting to avoid being deported to Cambodia or Vietnam in November 2019. They had separately committed crimes when they were each 19 years old. In December 2019, Newsom granted parole to a Cambodian refugee who had been held in a California prison due to a murder case. Although immigrant rights groups wanted Newsom to end policies allowing the transfer to federal agents, the refugee was turned over for possible deportation upon release. On January 13, 2022, Newsom denied parole to Sirhan Sirhan, Robert F. Kennedy's assassin, who had been recommended for parole by a parole board after serving 53 years in prison. Newsom wrote an op-ed for the Los Angeles Times saying Sirhan "still lacks the insight that would prevent him from making the kind of dangerous and destructive decisions he made in the past.

Sources: en.wikipedia.org

Notes from published material

We Happy Few is an action-adventure video game developed by Compulsion Games and published by Gearbox Publishing. In 2016, an early access version was released for Windows, with the full game seeing wide release for PlayStation 4, Windows, and Xbox One in August 2018. Played from a first-person perspective, the game combines role-playing, survival, and light roguelike elements. Taking place within the retro-futuristic version of the mid-1960s, following an alternative version of World War II, players take control over one of three characters, each of whom seek to complete a personal task while escaping the fictional city of Wellington Wells – a crumbling dystopia on the verge of societal collapse, due to the overuse of a hallucinogenic drug that keeps its inhabitants blissfully unaware about the truth of their world, while leaving them easily manipulated and lacking morals. The developers focused on creating a story with strong narratives, while underlining gameplay with a sense of paranoia, and designing in-game decisions that are of moral gray areas and weight, which influence and affect later parts of We Happy Few. Design of the game's setting was based on various elements of 1960s British culture, with developer Compulsion Games seeking inspiration on dystopian societies from various influences in the media, such as Brazil, Nineteen Eighty-Four, Animal Farm, Fahrenheit 451, Brave New World, and heavily on the MaddAddam trilogy.

As mayor of Nuevo Cuscatlán, Bukele described himself as part of the "radical left" because he wanted "radical changes" ("cambios radicales") for El Salvador; he also stated that his family had always had significant connections with the Salvadoran political left. Bukele believed in social justice and the state obligation to guarantee Salvadorans the opportunity for "health, education, [and] productive infrastructure" ("salud, educación, [e] infraestructura productiva"). Some FMLN members criticized Bukele's work as a businessman, believing that it contradicted the "historic goal of the proletariat" ("papel histórico del proletariado"): eliminating capitalism. Since becoming president, Bukele has stated that he does not adhere to any specific political ideology. He has criticized the political left and right in El Salvador for dividing the country after the civil war. In an interview with Time's Vera Bergengruen, he stated that he did not consider himself either left- or right-wing. El Faro's editorial board has described Bukele as a "politician without an ideology" ("político sin ideología"). Despite Bukele's ostensible ideologic neutrality, some journalists and political analysts have described him as a populist, a right-wing populist, and a conservative. Bukele himself has received support from conservatives abroad in both Latin America and the United States, particularly for his anti-crime policies, as well as criticism for democratic backsliding and consolidating power.

=== Dreamcast port === On February 14, 2000, Sierra announced that a port of Half-Life for the Dreamcast console was in development by Captivation Digital Laboratories with Valve and Gearbox Software. It would feature improvements including higher-polygon character models and new lighting effects. Gearbox, who had developed Opposing Force, created a new single-player campaign for the port, Half-Life: Blue Shift, focusing on the security guard Barney. The port was delayed to September 2000, then November, when game publications began to receive early copies for review. Reception was mixed, with criticism for the inconsistent frame rate, long loading times and lack of online play. Sierra planned to release a version with online multiplayer using SegaNet. The Gearbox CEO, Randy Pitchford, said he suggested adding multiplayer modes and mods from the Windows version, including Team Fortress Classic and the multiplayer modes from Opposing Force. Sierra delayed the port again and said they hoped to finish development that year. On March 29, 2001, Sierra announced that Blue Shift would be released for Windows along with the character models developed for the Dreamcast version, as part of the Half-Life High Definition Pack. On June 16, 2001, four days after the release of Blue Shift, Sierra announced that it had canceled the Dreamcast port, citing "changing market conditions". It was weeks away from its release date and virtually complete. In 2013, a late version of the Dreamcast port leaked online, featuring complete versions of Half-Life and Blue Shift.

TC/EA (or HTC, high temperature conversion; HTP, high temperature pyrolysis; HTCR, high temperature carbon reduction) is an "online" or "continuous flow" preparation method typically followed by IRMS detection. This is a "bulk" technique that measures all the hydrogen in a sample and provides the average isotope signal. The weighed sample is placed in a tin or silver capsule and dropped into a pyrolysis tube of TC/EA. The tube is made of glassy carbon with glassy carbon filling, so oxygen isotopes can be measured simultaneously without oxygen exchange with ceramic (Al2O3) surface. The molecules are then reduced into CO and H2 at high temperature (>1400°C) in the reactor. The gaseous products are separated through gas chromatography (GC) using helium as the carrier gas, followed by a split-flow interface, and finally detected by IRMS. TC/EA method can be problematic for organic compounds with halogen or nitrogen due to the competition between the pyrolysis byproducts (e.g. HCl and HCN) and H2 formation. In addition, it is susceptible to contamination with water, so samples must be scrupulously dried. An adaption of this method is to determine the non-exchangeable (C-H) and exchangeable hydrogen (bounds to other elements, e.g. O, S and N) in organic matter. The samples are equilibrated with water in sealed autosampler carousels at 115°C and then transferred into pyrolysis EA followed by IRMS measurement. TC/EA method is quick with fairly high precision (~1‰).

Sources: en.wikipedia.org

Background from the literature

==== Other territories ==== Australia. Ashmore and Cartier Islands - Special authorisation required. Belarus. Brest and Grodno - Visa not required for 10 days. China. Hainan - Visa not required for 30 days. China. Tibet Autonomous Region - Tibet Travel Permit required (10 USD). Colombia. San Andrés and Leticia - Visitors arriving at Gustavo Rojas Pinilla International Airport and Alfredo Vásquez Cobo International Airport must buy tourist cards on arrival. Ecuador. Galápagos - 60 days; Visitors must pre-register to receive a 20 USD Transit Control Card (TCT). Eritrea outside Asmara – To travel in the rest of the country, a Travel Permit for Foreigners is required (20 Eritrean nakfa). Fiji. Lau Province - Special permission required. Greece Mount Athos - Special permit required (4 days: 25 euro for Orthodox visitors, 35 euro for non-Orthodox visitors, 18 euro for students). There is a visitors' quota: maximum 100 Orthodox and 10 non-Orthodox per day and women are not allowed. India. Protected Area Permit (PAP) required for whole states of Nagaland and Sikkim and parts of states Manipur, Arunachal Pradesh, Uttaranchal, Jammu and Kashmir, Rajasthan, Himachal Pradesh. Restricted Area Permit (RAP) required for all of Andaman and Nicobar Islands and parts of Sikkim. Some of these requirements are occasionally lifted for a year. Iran. Kish Island - Visa not required. Kazakhstan. Closed cities - Special permission required for the town of Baikonur and surrounding areas in Kyzylorda Oblast, and the town of Gvardeyskiy near Almaty.

Prescott DJ, Vagelos PR (1972). "Acyl carrier protein". Advances in Enzymology and Related Areas of Molecular Biology. Advances in Enzymology - and Related Areas of Molecular Biology. Vol. 36. pp. 269–311. doi:10.1002/9780470122815.ch8. ISBN 9780470122815. PMID 4561013. Vance DE, Mitsuhashi O, Bloch K (1973). "Purification and properties of the fatty acid synthetase from Mycobacterium phlei". J. Biol. Chem. 248 (7): 2303–9. doi:10.1016/S0021-9258(19)44110-0. PMID 4698221. Williamson IP, Wakil SJ (1966). "Studies on the mechanism of fatty acid synthesis. XVII. Preparation and general properties of acetyl coenzyme A and malonyl coenzyme A-acyl carrier protein transacylases". J. Biol. Chem. 241 (10): 2326–32. doi:10.1016/S0021-9258(18)96625-1. PMID 5330116. Lowe PN, Rhodes S (1988). "Purification and characterization of acyl-carrier-protein acetyltransferase from Escherichia coli". Biochem. J. 250 (3): 789–96. doi:10.1042/bj2500789. PMC 1148925. PMID 3291856. Tsay JT, Oh W, Larson TJ, Jackowski S, Rock CO (1992). "Isolation and characterization of the β-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12". J. Biol. Chem. 267 (10): 6807–14. doi:10.1016/S0021-9258(19)50498-7. PMID 1551888. Rangan VS, Smith S (1997). "Alteration of the substrate specificity of the malonyl-CoA/acetyl-CoA:acyl carrier protein S-acyltransferase domain of the multifunctional fatty acid synthase by mutation of a single arginine residue". J. Biol. Chem. 272 (18): 11975–8. doi:10.1074/jbc.272.18.11975. PMID 9115261.

Conus geographus, part of the Encyclopædia Romana by James Grout. "Gastridium geographus". Gastropods.com. Retrieved 16 January 2019. Cone Shells - Knights of the Sea Photos of Conus geographus in the Sealife Collection

These include effects on chaperone proteins, which help fold proteins and remove misfolded ones; interactions with caspases, which play a role in the process of removing cells; the toxic effects of glutamine on nerve cells; impairment of energy production within cells; and effects on the expression of genes. Mutant huntingtin protein has been found to play a key role in mitochondrial dysfunction. The impairment of mitochondrial electron transport can result in higher levels of oxidative stress and release of reactive oxygen species. Glutamine is known to be excitotoxic when present in large amounts, that can cause damage to numerous cellular structures. Excessive glutamine is not found in HD, but the interactions of the altered huntingtin protein with numerous proteins in neurons lead to an increased vulnerability to glutamine. The increased vulnerability is thought to result in excitotoxic effects from normal glutamine levels. A somatic expansion of CAG repeats is involved in the progression of the disease. Over decades, the HTT gene first sees its CAG repeats expand to about 80 copies: the 35+ CAG locus causes additional slippage errors that expand the repeat. Then the process accelerates, reaching 150 copies within years. There is no significant toxic effect on the cell until 150 copies, at which point a large number of genes become progressively dysregulated. Over months, the medium spiny neuron slowly loses its cell identity until cell death pathways are activated.

The legislative branch of government is represented nationally by the Congress, a bicameral institution comprising a 166-seat Chamber of Representatives and a 102-seat Senate. The Senate is elected nationally and the Chamber of Representatives is elected in electoral districts. Members of both houses are elected to serve four-year terms two months before the president, also by popular vote.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.

Is SR9009 a steroid?

No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.

Has SR9009 been tested in humans?

Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.

What is SR9009?

SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.

Network